Clinical Trial Update: Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia [Phase 2]

View source ↗

Summary

LENZ Therapeutics completed a Phase 2 trial evaluating Aceclidine (LNZ101) alone and in combination with Brimonidine (LNZ100) for presbyopia; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• LNZ100 (Aceclidine)
• LNZ101 (Aceclidine/Brimonidine)

Snippet

Sponsor: LENZ Therapeutics, Inc | Conditions: Presbyopia, Refractive Errors | Phase 2 | Status: COMPLETED | Results posted: 2024-09-05